Recursion
Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us
Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery. Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas Leveraging the Power of Patient Data in AI-Drug Discovery Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
BioNeMo
AI tools and models for healthcare innovation.
NVIDIA BioNeMo™ is the development platform for AI-driven biology and drug discovery. NVIDIA Nemotron™ is the foundation for digital health AI. NVIDIA Isaac™ is a robotics and simulation platform. MONAI is the open medical imaging AI framework. The NVIDIA Holoscan SDK is a runtime for physical AI and sensor processing. NVIDIA Parabricks® enables GPU-accelerated genomics. Curated, domain-specific, open source datasets to kickstart model development. Prebuilt CUDA-X™ libraries for math, deep learning, data processing, image, video, and more. Hardware-optimized libraries, training recipes, frameworks, and orchestration platforms. Open source AI models for biomedical research across omics, protein and molecule structures, medical imaging, 3D anatomy, surgical robotics, and digital twins for physics-informed simulation. Tools for optimizing performance, scaling inference workloads, and deploying across cloud, on-prem, and edge environments. The architecture centers on a dual-die design that packs 208 billion transistors into a unified package capable of 10 terabytes per second (TB/s) of GPU bandwidth. Its Transformer Engine supports FP4 precision, effectively doubling performance and capacity for generative AI workloads. Massive-scale deployments are handled through NVIDIA NVLink™ and NVSwitch™, delivering 1.8 TB/s per GPU and 130 TB/s of aggregate bandwidth for trillion-parameter models. A dedicated Decompression Engine offloads data-intensive analytics tasks from the CPU, while AI-driven remote access service (RAS) monitoring and a first-of-its-kind trusted execution environment (TEE)-capable GPU round out the platform with enterprise-grade reliability and confidential computing support. Inception is a free program that guides AI startups through the diverse NVIDIA platforms and ecosystems. From prototype to production, Inception meets each startup where they are, with member benefits to help them discover new AI opportunities, build with world-class technologies, and grow their business. NVIDIA Connect is a free program that helps software development companies and service providers shorten time to market through tailored development resources, technical training and guidance, and preferred pricing on NVIDIA technologies. The NVIDIA Deep Learning Institute (DLI) offers technical training from NVIDIA, so developers and researchers can gain in-demand skills, hands-on experience, and expert knowledge in AI, data science, accelerated computing, and more. Our solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products, and services. Talk to an NVIDIA product specialist about your professional needs. Join the NVIDIA Developer Program to access free tech resources, support from forums, and expert training. Think of this as your personal guide to our "State of AI" reports. Whether you're curious about infrastructure o
Recursion
BioNeMo
Recursion
BioNeMo
Recursion (1)
BioNeMo (1)
Only in Recursion (10)
Only in BioNeMo (10)
Recursion
BioNeMo
Recursion
BioNeMo
